144 related articles for article (PubMed ID: 28419139)
1. Skeletal-related events and mortality among men diagnosed with advanced prostate cancer: The impact of alternative measures of radiation to the bone.
Onukwugha E; Kwok Y; Ciezki JP; Yong C; Plaisant C; Reddy CA; Mullins CD; Seal B; Valderrama A; Hussain A
PLoS One; 2017; 12(4):e0175956. PubMed ID: 28419139
[TBL] [Abstract][Full Text] [Related]
2. Mortality following bone metastasis and skeletal-related events among men with prostate cancer: a population-based analysis of US Medicare beneficiaries, 1999-2006.
Sathiakumar N; Delzell E; Morrisey MA; Falkson C; Yong M; Chia V; Blackburn J; Arora T; Kilgore ML
Prostate Cancer Prostatic Dis; 2011 Jun; 14(2):177-83. PubMed ID: 21403668
[TBL] [Abstract][Full Text] [Related]
3. Physician visits and the timing of skeletal-related events among men newly diagnosed with metastatic prostate cancer: A cohort analysis.
Onukwugha E; Albarmawi H; Sun K; Mullins CD; Aly A; Hussain A
Urol Oncol; 2018 Jul; 36(7):340.e23-340.e31. PubMed ID: 29724482
[TBL] [Abstract][Full Text] [Related]
4. Measurement of skeletal related events in SEER-Medicare: a comparison of claims-based methods.
Aly A; Onukwugha E; Woods C; Mullins CD; Kwok Y; Qian Y; Arellano J; Balakumaran A; Hussain A
BMC Med Res Methodol; 2015 Aug; 15():65. PubMed ID: 26286392
[TBL] [Abstract][Full Text] [Related]
5. Skeletal-related events and mortality among older men with advanced prostate cancer.
Onukwugha E; Yong C; Mullins CD; Seal B; McNally D; Hussain A
J Geriatr Oncol; 2014 Jul; 5(3):281-9. PubMed ID: 24726866
[TBL] [Abstract][Full Text] [Related]
6. The economic burden of skeletal-related events among elderly men with metastatic prostate cancer.
Jayasekera J; Onukwugha E; Bikov K; Mullins CD; Seal B; Hussain A
Pharmacoeconomics; 2014 Feb; 32(2):173-91. PubMed ID: 24435407
[TBL] [Abstract][Full Text] [Related]
7. The Clinical and Economic Impacts of Skeletal-Related Events Among Medicare Enrollees With Prostate Cancer Metastatic to Bone.
McDougall JA; Bansal A; Goulart BH; McCune JS; Karnopp A; Fedorenko C; Greenlee S; Valderrama A; Sullivan SD; Ramsey SD
Oncologist; 2016 Mar; 21(3):320-6. PubMed ID: 26865591
[TBL] [Abstract][Full Text] [Related]
8. Do skeletal-related events predict overall survival in men with metastatic castration-resistant prostate cancer?
Howard LE; De Hoedt AM; Aronson WJ; Kane CJ; Amling CL; Cooperberg MR; Terris MK; Divers CH; Valderrama A; Freedland SJ
Prostate Cancer Prostatic Dis; 2016 Dec; 19(4):380-384. PubMed ID: 27377207
[TBL] [Abstract][Full Text] [Related]
9. Risk of skeletal related events among elderly prostate cancer patients by site of metastasis at diagnosis.
Hussain A; Aly A; Daniel Mullins C; Qian Y; Arellano J; Onukwugha E
Cancer Med; 2016 Nov; 5(11):3300-3309. PubMed ID: 27730756
[TBL] [Abstract][Full Text] [Related]
10. Opioid Use Among Metastatic Prostate Cancer Patients With Skeletal-related Events.
Yaldo A; Wen L; Ogbonnaya A; Valderrama A; Kish J; Eaddy M; Kreilick C; Tangirala K; Shields K
Clin Ther; 2016 Aug; 38(8):1880-9. PubMed ID: 27478111
[TBL] [Abstract][Full Text] [Related]
11. Payer costs for inpatient treatment of pathologic fracture, surgery to bone, and spinal cord compression among patients with multiple myeloma or bone metastasis secondary to prostate or breast cancer.
Barlev A; Song X; Ivanov B; Setty V; Chung K
J Manag Care Pharm; 2010; 16(9):693-702. PubMed ID: 21067255
[TBL] [Abstract][Full Text] [Related]
12. Mortality following bone metastasis and skeletal-related events among women with breast cancer: a population-based analysis of U.S. Medicare beneficiaries, 1999-2006.
Sathiakumar N; Delzell E; Morrisey MA; Falkson C; Yong M; Chia V; Blackburn J; Arora T; Brill I; Kilgore ML
Breast Cancer Res Treat; 2012 Jan; 131(1):231-8. PubMed ID: 21842243
[TBL] [Abstract][Full Text] [Related]
13. Concordance between administrative claims and registry data for identifying metastasis to the bone: an exploratory analysis in prostate cancer.
Onukwugha E; Yong C; Hussain A; Seal B; Mullins CD
BMC Med Res Methodol; 2014 Jan; 14():1. PubMed ID: 24383436
[TBL] [Abstract][Full Text] [Related]
14. Economic evaluation of denosumab compared with zoledronic acid in hormone-refractory prostate cancer patients with bone metastases.
Xie J; Namjoshi M; Wu EQ; Parikh K; Diener M; Yu AP; Guo A; Culver KW
J Manag Care Pharm; 2011 Oct; 17(8):621-43. PubMed ID: 21942303
[TBL] [Abstract][Full Text] [Related]
15. An Approach to Identify Delivery of Palliative Radiation Therapy Using Health Care Claims Data: A Proof-of-Concept Application of a Visual Analytics Tool.
Onukwugha E; Jayasekera J; Gardner J; Malik S; Mullins CD; Hussain A; Ciezki JP; Reddy CA; Seal B; Valderrama A; Kwok Y
JCO Clin Cancer Inform; 2018 Dec; 2():1-12. PubMed ID: 30652549
[TBL] [Abstract][Full Text] [Related]
16. Factors predicting skeletal-related events in patients with bone metastatic castration-resistant prostate cancer.
Klaassen Z; Howard LE; de Hoedt A; Amling CL; Aronson WJ; Cooperberg MR; Kane CJ; Terris MK; Freedland SJ
Cancer; 2017 May; 123(9):1528-1535. PubMed ID: 28026865
[TBL] [Abstract][Full Text] [Related]
17. Race does not predict skeletal-related events and all-cause mortality in men with castration-resistant prostate cancer.
Patel DN; Howard LE; De Hoedt AM; Amling CL; Aronson WJ; Cooperberg MR; Kane CJ; Klaassen ZW; Terris MK; Freedland SJ
Cancer; 2020 Jul; 126(14):3274-3280. PubMed ID: 32374476
[TBL] [Abstract][Full Text] [Related]
18. Skeletal related events, bone metastasis and survival of prostate cancer: a population based cohort study in Denmark (1999 to 2007).
Nørgaard M; Jensen AØ; Jacobsen JB; Cetin K; Fryzek JP; Sørensen HT
J Urol; 2010 Jul; 184(1):162-7. PubMed ID: 20483155
[TBL] [Abstract][Full Text] [Related]
19. Beta-Adrenergic Antagonists and Cancer Specific Survival in Patients With Advanced Prostate Cancer: A Veterans Administration Cohort Study.
Posielski NM; Richards KA; Liou JI; Borza T; Abel EJ; Downs TM; Jarrard DF
Urology; 2021 Sep; 155():186-191. PubMed ID: 33587939
[TBL] [Abstract][Full Text] [Related]
20. Predictors of skeletal-related events and mortality in men with metastatic, castration-resistant prostate cancer: Results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database.
Tablazon IL; Howard LE; De Hoedt AM; Aronson WJ; Kane CJ; Amling CL; Cooperberg MR; Terris MK; Freedland SJ; Williams SB
Cancer; 2019 Nov; 125(22):4003-4010. PubMed ID: 31390061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
